Clinical Trial Update: Comparing the Efficacy and Safety of Rezvilutamide+ADT+Docetaxel Versus Rezvilutamide +ADT in the mHSPC [Phase 3]

View source ↗

Summary

Phase 3 trial comparing rezvilutamide with ADT and docetaxel versus rezvilutamide with ADT in metastatic hormone-sensitive prostate cancer is currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone Sensitive Prostate Cancer
• Prostate Cancer

Drugs mentioned

• ADT (androgen deprivation therapy)
• DOCETAXEL (DOCETAXEL)
• Rezvilutamide (rezvilutamide)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Metastatic Prostate Cancer, Hormone Sensitive Prostate Cancer | Phase 3 | Status: RECRUITING